Biotin Anti-Hepatitis C Virus antibody [NS5B-6]
Be the first to review this product! Submit a review
|
(4 Publications)
Mouse Monoclonal Hepatitis C Virus antibody - conjugated to Biotin. Suitable for ELISA, WB, ICC/IF, Flow Cyt (Intra) and reacts with Hepatitis C virus samples. Cited in 4 publications.
View Alternative Names
Genome polyprotein, HCV, Hepatitis C virus polyprotein
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Biotin Anti-Hepatitis C Virus antibody [NS5B-6] (AB122972)
ab122972, staining Hepatitis C Virus NS5b protein in Chimp liver cells infected with recombinant vaccinia virus containing a HCV genome cDNA by immunofluorescence.
- WB
Unknown
Western blot - Biotin Anti-Hepatitis C Virus antibody [NS5B-6] (AB122972)
NS5b protein is detected as a 58kDa band.
All lanes:
Western blot - Biotin Anti-Hepatitis C Virus antibody [NS5B-6] (ab122972)
All lanes:
Lysate of chimp liver cells infected with recombinant vaccinia virus containing a HCV genome cDNA
Predicted band size: 327 kDa
Observed band size: 58 kDa
false
Reactivity data
Product details
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Hepatitis C virus engages with host cell pathways to maintain its lifecycle. HCV forms replication complexes within host cells that are critical for its genome replication. These complexes actively interact with lipid metabolism processes which is why the virus associates closely with lipid droplets within hepatocytes. Through this interaction HCV affects host lipid homeostasis a component necessary for viral assembly and release. Since it forms structures that modify the host cell ER membrane understanding the HCV interaction with host cells is fundamental for therapeutic targeting.
Pathways
HCV has significant interactions with the innate immune response and lipid metabolism pathways. The virus disrupts interferon signaling by degrading proteins like IRF3 and blocking STAT1 phosphorylation undermining host antiviral defenses. Additionally HCV interplays with the PI3K-Akt-mTOR pathway important for host cell survival leveraging proteins such as Akt for its benefit. NS5A protein is known to modulate these pathways therefore influencing both the infection state and treatment strategies.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (4)
Recent publications for all applications. Explore the full list and refine your search
Autophagy 20:2238-2254 PubMed38842055
2024
Applications
Unspecified application
Species
Unspecified reactive species
Autophagy 16:2167-2179 PubMed31996071
2020
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in immunology 9:2176 PubMed30319633
2018
Applications
Unspecified application
Species
Unspecified reactive species
Virology 198:636-44 PubMed8291245
1994
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com